SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-064392
Filing Date
2022-03-03
Accepted
2022-03-03 16:29:14
Documents
17
Period of Report
2022-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d207740d8k.htm   iXBRL 8-K 29879
2 EX-99.1 d207740dex991.htm EX-99.1 95152
7 GRAPHIC g207740page08.jpg GRAPHIC 6019
8 GRAPHIC g207740page4.jpg GRAPHIC 3633
9 GRAPHIC g207740page4a.jpg GRAPHIC 5361
  Complete submission text file 0001193125-22-064392.txt   314292

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20220303.xsd EX-101.SCH 3941
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20220303_def.xml EX-101.DEF 13311
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20220303_lab.xml EX-101.LAB 21932
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20220303_pre.xml EX-101.PRE 14208
11 EXTRACTED XBRL INSTANCE DOCUMENT d207740d8k_htm.xml XML 5630
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 22709342
SIC: 2836 Biological Products, (No Diagnostic Substances)